"Oligoribonucleotides, Antisense" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Short fragments of RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.
- Oligoribonucleotides, Antisense
- Oligoribonucleotide, Antisense
- Antisense Oligoribonucleotides
- Antisense OligoRNA
- OligoRNA, Antisense
- Anti-Sense Oligoribonucleotides
- Anti Sense Oligoribonucleotides
- Oligoribonucleotides, Anti-Sense
- Anti-Sense Oligoribonucleotide
- Anti Sense Oligoribonucleotide
- Oligoribonucleotide, Anti-Sense
- Antisense Oligoribonucleotide
Below are MeSH descriptors whose meaning is more general than "Oligoribonucleotides, Antisense".
- Chemicals and Drugs [D]
- Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Antisense Elements (Genetics) [D13.150]
- Oligonucleotides, Antisense [D13.150.480]
- Oligoribonucleotides, Antisense [D13.150.480.645]
- RNA, Antisense [D13.150.650]
- Oligoribonucleotides, Antisense [D13.150.650.640]
- Nucleic Acids [D13.444]
- Nucleic Acid Probes [D13.444.600]
- Antisense Elements (Genetics) [D13.444.600.150]
- Oligonucleotides, Antisense [D13.444.600.150.640]
- Oligoribonucleotides, Antisense [D13.444.600.150.640.645]
- RNA, Antisense [D13.444.600.150.760]
- Oligoribonucleotides, Antisense [D13.444.600.150.760.640]
- RNA [D13.444.735]
- RNA, Antisense [D13.444.735.150]
- Oligoribonucleotides, Antisense [D13.444.735.150.640]
- Nucleotides [D13.695]
- Polynucleotides [D13.695.578]
- Oligonucleotides [D13.695.578.424]
- Oligonucleotides, Antisense [D13.695.578.424.480]
- Oligoribonucleotides, Antisense [D13.695.578.424.480.645]
- Chemical Actions and Uses [D27]
- Specialty Uses of Chemicals [D27.720]
- Laboratory Chemicals [D27.720.470]
- Molecular Probes [D27.720.470.530]
- Nucleic Acid Probes [D27.720.470.530.600]
- Antisense Elements (Genetics) [D27.720.470.530.600.150]
- Oligonucleotides, Antisense [D27.720.470.530.600.150.640]
- Oligoribonucleotides, Antisense [D27.720.470.530.600.150.640.645]
- RNA, Antisense [D27.720.470.530.600.150.760]
- Oligoribonucleotides, Antisense [D27.720.470.530.600.150.760.645]
Below are MeSH descriptors whose meaning is more specific than "Oligoribonucleotides, Antisense".
This graph shows the total number of publications written about "Oligoribonucleotides, Antisense" by people in Harvard Catalyst Profiles by year, and whether "Oligoribonucleotides, Antisense" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Oligoribonucleotides, Antisense" by people in Profiles.
Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions. Neuron. 2019 04 17; 102(2):294-320.
Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and Migration. Cell Rep. 2016 09 27; 17(1):261-274.
G2019S-LRRK2 Expression Augments a-Synuclein Sequestration into Inclusions in Neurons. J Neurosci. 2016 07 13; 36(28):7415-27.
Pharmacological therapies for Angelman syndrome. Wien Med Wochenschr. 2017 Jun; 167(9-10):205-218.
Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome. Am J Hum Genet. 2015 Oct 01; 97(4):555-66.
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol. 2015 Jan; 77(1):75-99.
Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest. 2015 Jan; 125(1):141-56.
Small RNA library construction from minute biological samples. Methods Mol Biol. 2014; 1093:123-36.
miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev. 2012 Oct 01; 26(19):2180-91.
MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012 Mar 22; 13(4):239-50.